Home > Healthcare > Pharmaceuticals > Finished Drug Form > Neuroprotection Market

Neuroprotection Market Share

Report ID: GMI8567
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Neuroprotection Market Share

The neuroprotection industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Neuroprotection Market Companies

Some of the eminent market participants operating in the neuroprotection industry include:

AbbVie Inc.
Biogen Inc.
Dr. Reddy’s Laboratories Ltd.
Eli Lilly and Company
GSK plc
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Neuroprotection industry size was USD 38.3 billion in 2023 and is estimated to exceed USD 70.7 billion by 2032 driven by rising need for safeguarding neuron structure and function in the brain and nervous system.

The antioxidants product segment is estimated to reach USD 14.7 billion by 2032, led by ongoing research underscoring the potential for slowing disease progression and preserving cognitive function.

Neuroprotection market from the oral route of administration segment recorded USD 24.9 billion in valuation in 2023, due to advancements in pharmaceutical formulations to improve efficacy, bioavailability, and stability of oral neuroprotection agents.

North America neuroprotection industry held 40.6% of the market revenue share in 2023 and will see expansion till 2032 owing to the presence of advanced healthcare infrastructure and research facilities.